(Q42951267)

11 November 2017

Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica (English)

1 reference

11 November 2017

Michael Levy

1

1 reference

PMC publication ID

4202676

11 November 2017

Maureen A Mealy

series ordinal

2

1 reference

11 November 2017

24 April 2014

1 reference

Neurology(R) neuroimmunology & neuroinflammation

11 November 2017

1 reference

11 November 2017

1

1 reference

11 November 2017

1

1 reference

11 November 2017

e5

1 reference

Neuromyelitis optica: an antibody-mediated disorder of the central nervous system

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

The spectrum of neuromyelitis optica

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Revised diagnostic criteria for neuromyelitis optica

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Acquired C1 esterase inhibitor deficiency

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Assessment of hereditary angioedema treatment risks

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Life on hold: the experience of living with neuromyelitis optica

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

C1-esterase inhibitor infusion increases survival rates for patients with sepsis*.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4202676

Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25340061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25340061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/NXI.0000000000000005

1 reference

11 November 2017

1 reference

PMC publication ID

4202676

11 November 2017

PubMed publication ID

25340061

1 reference

PMC publication ID

4202676